MedPath

Effectiveness of magnesium sulphate in improving spinal anesthesia when given in the subarachnoid space versus when given intravenously in lower limb surgeries.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/08/045072
Lead Sponsor
A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All adult male and female patients of age between 18-69 years and belonging to American society of Anaesthesiologists Physical status I & II posted for elective lower limb surgeries.

Consenting patients posted for elective lower limb surgeries.

Surgeries with a duration less than 2 hours(120 minutes).

Exclusion Criteria

Patient refusal.

Patients of age less than 18 years and more than 70 years.

History of allergy to drugs used in the study like ropivacaine, magnesium sulphate, paracetamol, ondansetron.

Lower limb surgeries lasting less than 30 minutes and more than 120 minutes.

All contraindications to spinal anesthesia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath